-
At Meta’s Antitrust Trial, a Bygone Internet Era Comes Back to Life
In the landmark antitrust case, tech executives have harked back to a Silicon Valley age when social apps like Facebook, Path, Orkut and Google Plus boomed.
-
Columbia Journalism Review Faces the Kind of Crisis It Usually Covers
The publication is now trying to find a successful business model without its top editor, who was abruptly fired last week.
-
Markets Gain After Trump Says He Has No Plans to Oust Fed Chief
Remarks on the Fed and tariffs by President Trump and his Treasury secretary fueled a rebound in global stocks.
-
Boeing Reports Smaller Loss but Trade War Threats Loom
The plane maker, which has been trying to recover from a quality crisis, could lose orders in China as a result of President Trump’s tariffs.
-
Trump Says He Won’t Fire Powell. His Fed Battle May Not Be Over Yet.
The president said he has “no intention” of ousting Jerome H. Powell, the Fed chair, but the administration’s willingness to challenge norms regarding the central bank’s political independence is causing concern.
-
Big Law Firms Fighting Trump’s Blacklist Seek Quick and Permanent Relief
Perkins Coie and WilmerHale hope to convince a pair of federal judges on Wednesday that President Trump’s threats to their business are blatantly unconstitutional.
-
Jared Kushner Targets Albania’s Adriatic Coast for Luxury Tourism
Two major proposals led by Jared Kushner and a new airport championed by the Albanian government focus on an area prized for its biodiversity. Are they a sign of things to come?
-
A White House Reporter on What It Takes to Cover Trump
Tyler Pager uses a deep bench of sources to break stories about immigration, economic policy and national security.
-
Trump Administration Sets New Direction for AI Policy
Objectives include the acceleration of the use and procurement of AI within the federal system, embracing AI governance as an enabler of innovation, and increasing investment in AI infrastructure to position the US as a global AI leader….By: Goodwin
-
Healthcare Life Sciences Drug Pricing Digest – April 2025 #2
On April 15, 2025, President Trump signed an executive order titled “Lowering Drug Prices by Once Again Putting Americans First.” The order includes various provisions that are relevant to the pharmaceutical industry, including the following……By: Latham & Watkins LLP
